Business ❯ Investing ❯ Investor Relations

Corporate Governance

Accessibility Policies Management Issues CEO Influence Public Offerings Securities Regulation Fiduciary Duties Shareholder Rights Securities Offerings Board Overhaul

ImmunityBio Investors Face May 26 Lead-Plaintiff Deadline in Securities Suit Tied to FDA Anktiva Rebuke

The case stems from an FDA warning that promotional claims for Anktiva were false or misleading, which drove a roughly 21% stock drop on March 24.

Halper Sadeh Opens Wide-Ranging Shareholder Probes Into New M&A Deals

Atara Biotherapeutics Hit With Investor Class Action as Firms Press May 22 Lead-Plaintiff Deadline

Navan IPO Lawsuit Spurs Investor Push Before April 24 Lead‑Plaintiff Deadline

Activist Shareholder Publishes 100-Page Critique, Pressures Square Enix to Rework Strategy

Disney Moves to Block Shareholder Review of Disability Access Changes After SEC Shift